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Recently, there has been a sharp rise in the use of cannabis products in the United 
States of America. This is largely due to decriminalization and legalization of marijuana 
across many states. However, marijuana remains illegal on the federal level because it 
contains the psychoactive component, Δ9-tetrahydrocannabinol (THC). THC is currently 
listed as a schedule I drug by Drug Enforcement Agent (DEA), meaning there is no accepted 
medical use, but it has a high potential for abuse. Therefore, cannabis products such as hemp 
oil sold in the United States cannot a concentration greater than 0.3% THC. 
The goal of this research project is to examine whether 5 commercial hemp oil 
products have less than the allowed THC concentration and determine the concentration of 
cannabidiol (CBD) via gas chromatography (GC) with flame ionization detector (FID) and 
mass selective detector (MSD). This research project described several experimental 
challenges of chemical analysis of CBD and THC in hemp oil via GC and development of 
experimental methods to quantify target compounds. Some experimental challenges 
described in this project are septum bleeding, degradation of target compounds, and 
decarboxylation of precursors. By the use of improved analytical method, CBD and THC in 
five hemp oil products were analyzed. It was found that CBD concentrations were 
significantly lower than advertised on the product label, and no traces of THC were detected 
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I. Introduction and Background 
1.1 Motivation and Objective   
 The use of hemp and marijuana in the United States can be traced back to the 1600’s. 
Hemp in particular was a highly coveted agriculture because of its versatility. It was often 
used to make clothing, rope and sails during those times. Marijuana was more widely used 
for medicinal purposes, such as pain relief, appetite stimulation, and counter opioid 
withdrawal. For nearly a century, marijuana was an ingredient used in a variety of medicine 
until the early 20th century. In 1910, Mexican immigrants sought refuge from the Mexican 
revolution and introduced recreational marijuana to the United States. As a result, Americans 
began to associate marijuana with the influx of Mexican immigrants.  This led to growing 
racism in the United States and eventually the illegalization of cannabis. 
 The Marijuana Tax Laws of 1937 was the first step to criminalizing cannabis 
nationwide. It placed taxes on the possession, sale and trading of any cannabis products in the 
United States; this included both hemp and marijuana. During this time, fear of drugs was 
becoming more prevalent in the United States, and President Nixon declared a “war on 
drugs.” The declaration imposed harsher drug laws, such as mandatory prison sentences, to 
mitigate public fear. He also created the Controlled Substance Act (CSA) of 1970, which 
allowed the federal government to regulate controlled substances [1]. The CSA separated 
known drugs into five different classification schedules. Depending on which classification 
schedule the drug was placed under, it would regulate how the substance was distributed, 
manufactured, and used. The CSA categorized the drugs based on their potential for abuse 
and addiction and whether they have legitimate medical use. Drugs, such as heroin, that have 
a high potential for abuse with no accepted medical use would be classified as a schedule I 
drugs. Whereas, Robutussin, a common cough syrup, would be classified as a schedule IV 
drug with low potential for abuse and accepted medical usage.  
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 Following the development of the CSA, cannabis, hemp and marijuana, were 
immediately deemed as a schedule I drug. This made it difficult for scientists and doctors to 
study the plant for medicinal purposes. It was not until 1996 when California became the first 
state to legalize marijuana for medical use and shortly afterwards, Colorado became the first 
state to legalize recreational use of marijuana. Finally, in 2018, hemp was officially removed 
from the CSA via the Hemp Farming Act of 2018. However, to this day, marijuana remains 
listed as a schedule I drug.  
As of 2021, 14 states have legalized the recreational use of marijuana and 16 states 
have decriminalized its use (Figure 1). Over 20 states allow for the sale of cannabis for 
medicinal use, whether through injection, inhalation or prescription medicine. Marijuana 








Figure 1. Legal status for marijuana across the United States. Obtained from Marijuana 
Policy Project. 
 
It is a common misconception that marijuana and hemp are two different species of 
plant. However, they are in fact just two different names for Cannabis sativa L., a flowering 
plant in the Cannabaceae family. Although science does not differentiate between 
“marijuana” and “hemp,” the law separates the two based on the level of 
tetrahydrocannabinol (THC) present. Federal law defines hemp as “the plant Cannabis sativa 
L. that contains 0.3% or less THC content by dry weight,” [2] whereas marijuana is any 
cannabis that contains over 0.3% THC content.  
The main reason for the two plants to be differentiated legally, is because 
consumption of THC to a certain amount can cause psychological effects. Cannabis sativa L. 
is comprised of over 100 cannabinoids, but THC is the primary psychoactive component. 
Routine marijuana smokers have shown signs of “subtle working memory impairment,” 
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mood swings and an altered sense of time [3]. Working memory refers to the ability to store 
and manipulate the information to produce a response. For instance, an individual under the 
influence of marijuana would have more difficulty reciting a particular sentence backwards 
compared to a sober individual.  
  As more states legalize and decriminalize marijuana, many companies are eager to 
introduce new innovational CBD and hemp products into the market. Since Colorado 
legalized recreational marijuana in 2012, CBD products have saturated the market in various 
forms including oils, edibles, vaporizers, creams etc. It is now very common to see these 
products sold all across the U.S. and even for online purchase. Currently, in New York, CBD 
products derived from marijuana are considered illegal. However, CBD products derived 
from hemp can be sold as long as they follow state regulations. The Department of Health 
allows for the “intermediate sales of hemp extract containing up to 3.0% THC…provided that 
the sale is between licensed processors in New York State” [10]. However, hemp extract 
products are not required to be labeled with the concentration of CBD in the product. In 
comparison, products extracted from marijuana are legally obligated to disclose the amount 
of milligrams of THC and CBD per serving [10]. 
  The main focus of this study was to determine if five commercial hemp oil follow 
federal and New York state regulations; in addition to whether the amount of CBD was 
reflective of the amount printed on the product label. This study also addressed the challenges 
faced when performing chemical analysis of CBD and THC via gas chromatography. 
 In the current study, both GC-FID and GC-MSD were utilized to analyze CBD 
compound in hemp oil samples. The reasoning behind using both GC-FID and GC-MSD was 
because the GC-FID produces a stronger signal and is more sensitive for quantitative 
analysis. While the GC-MSD provides qualitative information, such as chemical structure of 
the compound [11]. The GC-MSD is also useful in identifying any unknown compound that 
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may be present in the hemp oil sample matrix. With the allowance of up to 0.3% THC, this 
quantitative experiment served to determine if there were any evidence of THC violation and 
whether the concentration printed on the label refers to CBD concentration. 
1.2 Endocannabinoid and Phytocannabinoid 
  In the past, cannabinoids were thought to be naturally occurring compounds derived 
solely from the Cannabis sativa L. plant. However, in 1990, the cannabinoid 1 (CB1) 
receptor in the human body was discovered by Allyn Howlett and William Devane. Shortly 
after, the endocannabinoid system was discovered in 1992. The finding of the 
Endocannabinoid system was significant because it implied that the human body produces its 
own cannabinoids similar to the ones produced by cannabis. Cannabinoids produced by 
plants are called phytocannibinoids and cannabinoids produced by mammals are called 
endocannabinoids. Phytocannabinoids react to the endocannabinoid receptors in the body [4] 
and could be the reasoning behind why THC and CBD derived from marijuana have such a 
strong effect on humans. The main purpose of the endocannabinoid system is to help the 
body maintain homeostasis. There are two main cannabinoid receptors, CB1 and cannabinoid 
receptor 2 (CB2).  CB1 is most abundant in the Central Nervous System (CNS), whereas 
CB2 is primarily located on immunological tissues. Since these cannabinoid receptors are 
ubiquitous throughout the human body, it explains why smoking marijuana can affect 
cognition, mood, pain, appetite, and nausea. Since the human body already utilizes 
endocannabinoids to maintain different bodily functions, it naturally follows that 
phytocannabinoid will also affect the same bodily functions. Although there are many other 
cannabinoid receptors, CB1 and CB2 receptors are the most studied.  
1.3 Mechanism of THC and CBD 
  CBD is an isomer of THC, with both sharing the same molecular weight of 314 
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g/mol. THC is the primary psychoactive component in Cannabis sativa L. and is responsible 
for the ‘high’ people experience when smoking marijuana. In comparison, CBD does not 
produce any psychoactive effect. This could be due to the differences in chemical structure 
and how they interact with the receptors in the body. Although they are both comprised of the 
same molecular formula, CBD has a hydroxyl group and THC has a cyclic ring (Figure 2). 
The broken ring in CBD allows it to bend in the 3-dimension, whereas THC has a more rigid 
and flat structure.  
 
Figure 2. Chemical structure of THC and CBD. 
There are currently 113 known phytocannabinoids, but CBD and THC are by far the 
two most studied phytocannabinoid. Cannabinoids are composed of a phenol group and a 5-
carbon chain. When cannabis is consumed, CBD and THC binds to either CB1 or CB2. 
However, THC has a higher affinity to bind to CB1, which is located primarily in the central 
nervous system. Since THC is a partial agonist, it stimulates the CB1 receptors to produce 
psychological effects. This response includes that overwhelming euphoric feeling marijuana 
users get addicted to. One possible explanation why CBD does not exhibit the same 
psychotropic effect as THC is that CBD is a negative allosteric modulator [4]. A negative 
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allosteric modulator alters the shape of the receptor by binding to a secondary site on the 
receptor, thus making it difficult for CB1 agonist, such as THC, to produce a psychotropic 
response. Since CBD does not actually bind or stimulate the CB1 receptor, it could explain 
why cannabis users tend to not experience the same ‘high’ when consuming CBD-only 
products. The exact mechanism for how THC and CBD interacts with the body is still the 
subject of ongoing research.  
1.4 Analysis of Cannabis Products  
  Before cannabis products are allowed to enter the market, they must go through a 
series of tests prior to approval. Cannabis product testing differs from state to state, but the 
four most common tests are potency testing, residual solvent testing, heavy metal testing and 
lastly, pesticide testing. Potency testing is the reporting of the dry weight of THC and CBD in 
the product. This is typically done using high performance liquid chromatography (HPLC) or 
gas chromatography-mass spectrometry (GC-MS) [6]. Residual solvent tests for any residual 
solvent that may have been left over in the product during the extraction process. Ethanol, 
methanol and other organic solvents are the most commonly used solvents in the extraction 
process for CBD. Testing for these residual solvents is critical in preventing risk of alcohol 
toxicity and death. Presently, the U.S. Food and Drug Administration (FDA) has established 
a limit of no more than 200 ppm of ethanol or methanol to be present in any consumable 
product [7]. 
  In the same sense, cannabis products also need to be tested for any heavy as exposure 
to high concentration of heavy metals can be lethal. Cannabis products may contain traces of 
heavy metal because the plant could have taken it in from the soil or fertilizers. Lastly, 
pesticide testing screens for the presence of any pesticides that may have ended up in the 
products. But which pesticides to screen for varies greatly across the country. For example, in 
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California, CBD products must test for 55 different types of pesticides, whereas in Colorado, 
it is only required to test for 13 types of pesticides. 
1.5 Gas Chromatography 
  Gas chromatography can be coupled with several detectors, but typically organic 
compounds are analyzed using either flame ionization detector (FID) or mass spectrometry 
detector (MSD). GC technology started in the 1950’s by Anthony T. James and Archer J. P. 
Martin of the National Institute for Medical Research. The technique was later built upon to 
accommodate other analytical techniques, such as the mass spectrometry (MS), and 
eventually evolved into the GC-MSD. Now, the GC-MSD is commonly used for quick 
chemical analysis in forensics, drug analysis, medical labs, and many more.  
  In general, chromatography is a laboratory technique used to separate different 
components of a solution. Once the components are separated, they can be analyzed 
individually. Typically, for GC, a sample is injected by a syringe through a septum into a 
heated chamber. The septum serves to seal the injection port and prevent any compounds 
from leaking out. The heat vaporizes the sample, and the carrier gas pushes the sample into a 
capillary column. The analytes are then separated in the capillary column. Separation is 
dependent on the size of the analytes and its affinity to the stationary phase. Analytes that are 
smaller and have less affinity to the stationary phase will elute faster. Larger analytes with a 
higher affinity to the stationary phase, meaning it will interact more with the column, will 
elute slower. As the compounds elute from the column, it is detected by the detector.  
1.5.1  GC-FID Instrumental Operation  
  For FID, it detects ions formed through combustion in a hydrogen flame (Figure 3). 
As compounds elute from the column, hydrogen mixes with the carrier gas containing the 
compounds. A flame is ignited by burning hydrogen, air and the carrier gas. As the analytes 
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are burnt by the flame, hydrocarbons will produce ions. These ions are then detected by a 
collector that sends signals to be converted into peaks.  
 
 
Figure 3.  Overview of GC-FID analytical instrument. 
1.5.2 GC-MSD Instrumental Operation 
 Similar to the FID, the MSD evaluates the individual compounds that elute out of the 
GC column. However, instead of passing through a flame, the analytes are bombarded with 
electrons to break them into molecular ions and fragments of these molecular ions (Figure 4).  
These ions then travel through a quadruple mass analyzer that filters them based on their size. 
A quadruple mass analyzer is made of four parallel rods with a space for the central axis to 
allow ions to travel through [8].   Superimposed direct current (DC) and alternate current 
(AC) voltages are applied at each opposing pair of electrodes. The DC and AC voltages are 
varied linearly while keeping the ratio constant. As ions pass through the oscillating electric 
field, they are filtered based on their mass-to-charge ratio (m/z) and only ions with a certain 
m/z will pass through the quadruple to be detected. Ions with a m/z outside of the specified 
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voltage will not be able to pass through the quadruple, and thus will not be detected [9]. After 
passing through the quadruple, the MSD calculates how many of each ion with a particular 
mass was present in the sample. This information is presented as mass spectra and 
compounds can be identified based on the mass spectra produced.  
 
Figure 4.  Overview of GC-MSD analytical instrument. 
II. Materials and Methods  
2.1 Reagents and Standards 
  THC and CBD were purchased from Cerilliant Corporation (Round Rock, Texas 
USA) with a 1.000  0.005 mg/mL concentration in methanol (Figure 5). The five 
commercial hemp oil samples were purchased on Amazon. Most of the hemp oils came in 30 
mL amber bottles and were immediately refrigerated upon receiving. Methanol and 





Figure 5. Photograph of (a) commercial hemp oil samples and (b) CBD and THC standards 
in methanol.  
2.2 Collection of Samples  
  In this study, five hempseed oils samples were purchased and tested. The five brands 
of hemp oil being tested were O’rmeas, Hempio, Hemp Techniques, Greenive, and Zatural. 
All five hemp oils were sourced from the United States of America. O’rmeas, Hemp 
Technique, Greenive and Zatural listed hemp seed oil as their sole ingredient in their product. 
Hempio’s ingredient list included hemp seed oil, vitamin A, vitamin E, and vitamin C. The 
samples varied from 300 mg to 35,000 mg per bottle according to the label.  
2.3 Sample Preparation and Extraction 
  An external calibration curve was created for both CBD and THC. The stock 
solutions were purchased at a concentration of 1.000  0.005 mg/mL (~1000 ppm). The 
solutions were then further diluted to 5 ppm, 10 ppm, 50 ppm, 100 ppm, and 250 ppm and 
these became the calibration standards. The calibration standards were used to generate the 
calibration curve for the GC-FID. The standards were diluted with HPLC-grade methanol. 
After the dilutions, 1 µL was injected into the analytical system. Each sample was analyzed 
in quadruplicate.  
  The hemp oil samples were diluted with chloroform because they were not miscible 
with methanol. Initially, the hemp oil samples were diluted by a factor of 5; however, two of 
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the five samples did not fall within the calibration range. Therefore, they were further diluted 
by a factor of 50 as shown in Table 1. Lastly, 1 L aliquot was injected into the GC-FID for 
analysis. All solutions were kept in amber bottles and stored in a refrigerator set to - 20 °C. 
 
Table 1. Dilution factors of hemp oil samples.  
Sample Dilution 
Hempio 1:5 




2.4 Instrumental Parameters 
  Two distinct gas chromatography (Agilent Technologies 7890A) instruments were 
used, one was coupled with the internal FID and the other was coupled with the MSD 
(Agilent Technologies 5975C). Both used a 5% phenyl methyl siloxane capillary (HP-5MS) 
column and helium was the carrier gas. The GC-FID used a HP-5MS, 30 m × 0.25 mm × 
0.25 m column and the GC-MS used a HP-5MS, 30 m × 0.25 mm × 1 m column. Each 
sample was introduced into a heated inlet set to 260 C to ensure the sample was completely 
vaporized prior to entering the column. For the GC-MSD, the final temperature of 300 °C 
was held for 2 min longer than the GC-FID because the GC-MSD had a slightly thicker 
stationary phase compared to the one installed in the GC-FID. The GC’s oven temperatures 
were optimized for each instrument to achieve complete separation during the elution phase 
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(Table 2-3). Since the GC-MSD had a larger column compared to the GC-FID, the GC-MSD 
had a higher flow rate of 2.5 mL/min and a split ratio of 10:1; whereas the GC-FID had a 
flow rate of 1.5 mL/min and a split ratio of 25:1. The injection volume for both instruments 
were 1 L aliquots. After compounds eluted from the GC column, they were bombarded with 
a 70-eV electron bean that fragmented the compounds in the MSD. The quadrupole was set 
to 150 C while it sorted out ions before detection. The ions monitored for the GC-MSD were 
at m/z 299 and 314 for THC, and m/z 231 and 246 for CBD [12]. 
Table 2. GC-FID oven temperature.  
Temperature (°C) Rate of Increase (°C/min.) Hold time (min.) 
160 °C - 1 
190 °C 15 1 
300°C 20 2 
 
Table 3. GC-MSD oven temperature. 
Temperature (°C) Rate of Increase (°C/min.) Hold time (min.) 
160 °C - 1 
190 °C 15 1 
300°C 20 4 
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2.5  Septa Experimental Details 
  Three different septa (Figure 6) were tested at three different inlet temperatures to 
determine which septum showed the least amount of bleeding and interference. The three 
septa tested were a red septum from Agilent Technologies (inlet septa, general purpose, red 
5mm), a teal septum from Restek (Thermolite® septa), and a gray septum from Agilent 
Technologies (inlet septa, general purpose, gray 5mm). The experiment was conducted on the 
GC-FID (Agilent Technologies 7890A) under the same parameters presented in Table 2. 
Each septum was tested at in inlet temperature of 220 °C, 260 °C, and 300 °C. Once a septum 
was installed, the method was immediately run to examine septum bleeding effect before 
conditioning. This was done to gauge how effective conditioning a septum was in preventing 
septum bleeding. All GC measurements were conducted at each of the three inlet temperature 
and conditioned for 30 hrs  5 min at 300 °C. The start and end times for conditioning are 
shown in Table 4. Following conditioning, each septum was rerun at the three different inlet 
temperatures using the same method as before conditioning.  
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Figure 6. Photographs of the three septa used in this study. 
 
Table 4. Conditioning timetable for each septum. 
Septum Date and Time Started Date and Time Ended 
Teal 02/10/21 – 6:12 PM 02/11/21 – 12:12 PM 
Gray 02/11/21 – 6:05 PM 02/12/21 – 12:06 PM 





III.  Results and Discussion 
3.1 Septum Interference  
One challenge faced during the analysis of hemp oil via gas chromatography is the 
possibility of septum interference or septum bleeding. At high temperatures, the septum 
could bleed into the GC column and result in ghost peaks. These peaks on the chromatogram, 
but the corresponding compound may not necessarily be present in the sample. These ghost 
peaks cause interference during detection and quantification of compounds. Ghost peaks 
could also hinder reproducibility of results. One example of how septum bleeding occurs is 
volatile organic compounds (VOC) could be trapped in the septum. When running the GC 
instrument, the high inlet temperature causes the trapped VOCs to be released from the 
septum and bleed into the column, resulting in ghost peaks. Particularly, in the GC-FID, the 
capillary columns are very narrow with a typical flow rate of less than 2 mL/min, which 
could result in VOCs becoming very concentrated and cause bleeding to be more pronounced 
[13]. Another source for ghost peaks is the bleeding of the actual septum material itself. All 
septa are comprised of multiple compounds such as silicone oils, long hydrocarbons, 
phthalates, etc. At high temperature, these septum material can be released and result in 
septum interference [13].  
3.1.1 Teal Septum 
 In order to minimize the effects of septum bleeding, three different septa were tested 
to see which septum was most suited for hemp oil analysis. For the teal septum, there were 
peaks observed at all three injection port temperatures, regardless of conditioning. Their 
respective chromatograms are shown in Figure 7-12. These peaks started to appear around 
the 7.5-min mark and persisted until the end of the run time, around 11.5 min. At 220 °C, 
there was a significant amount of bleeding prior to conditioning (Figure 7). Figure 8 shows 
the chromatogram at 220 °C after conditioning and there were visibly less crowding of peaks. 
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This pattern remained constant for the remaining injection port temperatures as well. (Figures 
9-12). Comparing the post-conditioning chromatograms, there were the least amount of peak 
interference at 260 °C and 300 °C showed the most amount of peak interference.  
 
 





















Teal Septum 220°C Pre-Conditioning 
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Figure 8. GC chromatograms of teal septum observed at 220 °C after conditioning.   
 










































Teal Septum 260°C Pre-Conditioning 
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Figure 10. GC chromatograms of teal septum observed at 260 °C after conditioning.   
 



































Teal Septum 300°C Pre-Conditioning 
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Figure 12. GC chromatograms of teal septum observed at 300 °C after conditioning.   
3.1.2 Gray Septum  
In case of the gray septum, there were ghost peaks observed at all three injection port 
temperatures, but considerably less compared to the teal septum. The chromatograms for the 
gray septum at each inlet temperatures are shown in Figures 13-18. Comparing the pre-
conditioning graphs to its corresponding post-conditioning graphs, there were visibly less 
peaks after conditioning at each inlet temperature. After conditioning, septum performance 
seems to be equal, where chromatograms had only some small peaks around retention time at 





















Teal Septum 300°C Post-Conditioning 
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Figure 13. GC chromatograms of gray septum observed at 220 °C before conditioning.   
 




































Gray Septum 220°C Post-Conditioning 
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Figure 15. GC chromatograms of gray septum observed at 260 °C before conditioning.   
  

































Gray Septum 260°C Post-Conditioning 
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Figure 17. GC chromatograms of gray septum observed at 300 °C before conditioning.   
 






































Gray Septum 300°C Post-Conditioning 
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3.1.3 Red Septum  
Lastly, for the red septum there was not as a significant change between pre-
conditioning and post-conditioning chromatogram at each inlet temperatures. The 























Red Septum 220°C Pre-Conditioning 
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Figure 20. GC chromatograms of red septum observed at 220 °C after conditioning.   
 






































Red Septum 260°C Pre-Conditioning 
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Figure 22. GC chromatograms of red septum observed at 260 °C after conditioning.   
 






































Red Septum 300°C Pre-Conditioning 
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Figure 24. GC chromatograms of red septum observed at 300 °C after conditioning.  
3.1.4 Septum Bleeding Results and Discussion 
As shown in Figures 7-24, chromatograms remained free from any ghost peaks in all 
three septa when oven temperatures were held at 160 °C and 190 °C. However, when oven 
temperatures ramped up to > 200 °C, multiple peaks started to appear in the teal and gray 
septum before conditioning. Since GC experimental parameters, such as the oven-heating 
temperature and carrier gas remained constant for the entirety of the septum test, the observed 
peaks were ascribed to septum bleeding. Out of the three septa, the red septum had the least 
number of observed peaks at temperatures above 200 °C and the teal septum had the highest 
amount. This could be due to the fact Restek Thermolite® septum, has a maximum 
temperature of 340 °C, whereas the Agilent general purpose septum has a maximum 
temperature of 400 °C. All three septa showed visibly less bleeding after conditioning for 30 
hrs. As a result of this test, the most suitable septum for testing hemp oil samples was 

















Red Septum 300°C Post-Conditioning 
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In all of the chromatograms, there was a rise in baseline after the GC oven 
temperature began to ramp up to 300 °C around the 6 min mark. The rise in baseline could be 
attributed to possible column bleeding of cyclic siloxane or any oxygen trapped in the phase 
that was not fully purged during conditioning. As temperatures ramp up, the stationary phase 
can be susceptible to bleeding and detected by the GC-FID. Another possible explanation for 
the rising baseline is that oxygen was not fully purged during conditioning, meaning the 
carrier gas was not allowed to flow through the column long enough prior to running the 
samples. This could result in further phase oxidation as the oven temperature ramps up and 
contribute in rising baseline [14]. Nonetheless, the rise in baseline does not interfere with the 
results of the septa experiment because column bleeding is different from septum bleeding. 
Septum bleeding results in distinct peaks as seen in Figure 15 rather than a steady incline as 
seen in Figure 23. 
3.2 Test for Decarboxylation of CBDA 
  Another issue researchers must keep in mind when quantifying CBD via GC, is 
decarboxylation [15]. Cannabidiolic acid (CBDA) and tetrahydrocannabinolic acid (THCA) 
are the most abundant cannabinoids found in the cannabis plants. Hence, it would not be 
surprising to find traces of CBDA and THCA in cannabis products such as CBD and hemp 
oil. When CBDA and THCA are exposed to high heat, it undergoes decarboxylation and the 
compounds are converted to CBD and THC, respectively. Decarboxylation is a chemical 
reaction that removes a carboxyl group and produces carbon dioxide as a biproduct. When 
samples are injected into the GC instrument, the high inlet temperature causes CBDA and 
THCA in the sample to decarboxylate and their products are detected in the chromatogram. 
Therefore, when quantifying CBD in the hemp oil samples, it includes the total concentration 
of CBD, including any CBDA that was decarboxylated from the high injection temperature.  
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 For the purpose of proving decarboxylation occurred, salicylic acid was injected into 
the GC instrument. At the time of the experiment, CBDA and THCA were unavailable for 
purchase, subsequently salicylic acid was used instead to mimic the decarboxylation of 
CBDA. Similar to CBDA, salicylic acid also contains a carboxyl group that can be 
decarboxylated. When salicylic acid is decarboxylated, it produces phenol and carbon 
dioxide. Looking at the chromatogram of salicylic acid (Figure 25), there are two significant 
peaks observed at 6.9 and 11.8 min. The peak with the stronger signal at 11.8 min was 
identified to be salicylic acid and the peak at 6.9 min was suspected to be phenol. In order to 
confirm the peak corresponded to phenol, phenol was injected into the GC-FID using the 
same method to test salicylic acid (Figure 26). Since GC-FID only generates retention time, a 
positive identification of a compound is only possible by confirming the known retention 
time of the desired compound.  
 The chromatogram for phenol revealed a strong peak at 6.9 min, which matches the 
same retention time of the unknown peak in salicylic acid.  Comparing the two 
chromatograms, it proved salicylic acid underwent decarboxylation because when only 
salicylic acid was injected, there was a positive confirmation for the presence of phenol in the 
sample. This experiment confirmed that decarboxylation can occur due to the high 




Figure 25. GC-FID for salicylic acid. 
 






































3.3 Derivatization of Cannabinoids  
  A common method to protect compounds from decarboxylation is to derivatize them. 
Derivatization is the process by which a compound is chemically changed, to produce a new 
compound that makes it more suitable for an analytical instrument, or in this case the GC. 
Derivatization is useful for research because it prevents decarboxylation, protects hydrophilic 
ends, creates better separation and resolution, and helps with the reproducibility of results.  
For cannabinoids, silylation is the most common derivatization technique. In silylation, the 
silylation reagents react with compounds containing hydroxyl groups by replacing it with an 
alkyl silyl group, typically trimethylsilyl. For example, in Figure 27, CBDA is coupled with 
bis(trimethylsilyl) acetamide to protect the hydrophilic ends. This resulted in a derivatized 
CBDA where the hydroxyl groups were replaced with trimethylsilyl groups.  
 
 
Figure 27. Derivatization of CBDA using silylation. 
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  Due to lack of time and resources, CBDA was not derivatized before testing the hemp 
oil samples. Therefore, the concentration of CBD detected in the GC included the total 
amount of CBD, including those that may have come from CBDA.  
3.4 Photodegradation of CBD 
Lastly, photodegradation is a prevailing challenge when analyzing CBD via GC [16]. 
Photodegradation is the alteration of compounds through light. Previous research had shown 
CBD to degrade over time due to light and heat [16-19]. Depending on the temperature and 
the amount of light CBD is exposed to, it can degrade by 15% in a month [17] and sometimes 
even by 50% over a period of two months [19]. This research utilized the GC-MSD to 
conduct a degradation study over a period of 5 months on the CBD standard. The CBD 
standard (1.000  0.005 mg/mL) was first tested on the GC-MSD in September 2020 and 
again in February 2021 (Figure 28).   
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Examining the two chromatograms, both detected CBD and produced a corresponding 
CBD peak at a retention time of 10.5 min. This peak was confirmed to be CBD by analyzing 
the mass spectra (Figure 30) of the peak and identifying it based on the library search 
function on the GC-MSD. The GC-MSD library search function matched the fragmentation 
pattern of each analyte and correlate it to a known database in the software for an 
identification. Not only was it confirmed using the internal database, but it was also further 
confirmed to be CBD by comparing the fragmentation pattern to the literature value found on 
the NIST Chemistry WebBook. The CBD mass spectra (Figure 29) matched the spectra 
provided by NIST Chemistry WebBook (Figure 30) with both spectra having peaks at m/z = 
174, 193, 231, 246, and 314.  
 
 





Figure 30. Mass Spectra of CBD standard. Obtained from NIST WebBook. 
Comparing the CBD peaks taken in September and February, the signal intensity was 
much stronger in September compared to February, where the signal intensity was about 
800,000 au versus 350,000 au, respectively. Furthermore, upon closer examination, there was 
a second peak around the 7-min mark in the chromatogram taken in February. This peak 
indicated the presence of another compound in the sample and most likely resulted from the 
photodegradation of CBD over time. Unfortunately, there was no positive identification of 
for compound peak using the library search function in the GC-MSD. Regardless, after this 
experiment, it was confirmed that the CBD standard had degraded to some degree. This led to 
extra measures taken to ensure the hemp oils to be analyzed were relatively new and had not 
been sitting on the shelf for a long period of time.  
3.5 Cannabinoid Elution Order 
When running the GC, the chromatograms provide two crucial pieces of information: 
peak area and retention time. The retention time indicated when the compounds are detected 
during the method and the peak area correlates with its concentration. The peak area can vary 
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depending on the amount of compounds in the sample, human errors, or instrumental errors. 
However, the retention time should remain constant for identical compounds.  
Prior to starting the research, it was important to establish the elution order of CBD 
and THC in the optimized method. This was done by injecting 1L of each cannabinoid at 
1000 ppm into the GC-FID to determine the time frame in which these compounds would 
elute. Figure 31 shows the elution order of CBD and THC using the optimized method 
previously discussed. The total run time on the GC-FID was 11.5 min and two peaks were 
observed at 9.6 and 10.1 min. CBD was identified to elute from the column at 9.6 min and 
THC eluted out shortly after at 10.1 min. 
 
 






3.6 Calibration Curves 
An external calibration curve was created for both CBD and THC by creating a series 
of dilution at 5 ppm, 10 ppm, 50 ppm, 100 ppm, and 250 ppm for each compound. There 
were no interfering peaks observed around the retention time of cannabinoids.  The  signal 
intensities of cannaboids changed between the varying concentrations. However, the 
retention time remained consistent. The peak area was calculated by integrating the area 
under the peak using the Agilent CDS ChemStation software. Figures 32 and 33 show the 
calibration curve for each cannabinoid created with data from the GC-FID.  
 
 
Figure 32. The external calibration curve for CBD using GC-FID. 
 



















Figure 33. The external calibration curve for THC using GC-FID. 
A comparison between the linearity of the two compounds are shown in Table 5. THC 
produced more linear data compared to CBD in the FID. The correlation coefficient (R2) 
value for both were above 0.99, which indicates the curve to be well-fitted. These were the 
calibration curves used to quantify the total amount of CBD and THC in hemp oil samples. 
Table 5. Comparison between the linearity of the calibration curves for CBD and THC. 
Cannabinoid Equation of Line R2 (FID) 
CBD y=0.011x-0.0123 0.9906 
























3.7 Hemp Oil Quantitative Results 
The main purpose of this experiment was to determine if there were any quantifiable 
CBD and THC in five brands of hemp oil while being mindful of all the potential challenges 
that are commonly associated with GC analysis.  
 The O’Rmeas hemp oil had a peak around 9.5 min, which has previously been 
identified as CBD (Figure 34). There were no visible peaks at 10 min retention time, which 
suggested there were no detectable THC in this hemp oil sample. This was not surprising 
since hemp plants typically contain low levels of THC compared to marijuana plants.  Hemp 
Technique did not show any distinct peaks at both retention time 9.5 and 10 min (Figure 35).  
Thus, there were no detectable amount CBD or THC in this hemp oil. Figures 36-38 are the 
chromatograms for Hempio, Greenive, and Zatural, respectively. They all had a visible CBD 
peak at around 9.5 min and had no detectable THC. In Hempio, the chromatogram was 
crowded with significantly more peaks compared to the other hemp oil brands. This could be 





Figure 34.  GC-FID chromatogram of O’Rmeas hemp oil.  
 











































Figure 36.  GC-FID chromatogram of Hempio hemp oil. 
 








































Figure 38.  GC-FID chromatogram of Zatural hemp oil. 
Overall, four out of the five brands of hemp oils had a detectable amount of CBD. 
None of the hemp oil had any detectable levels of THC present. Each of the hemp oil had a 
concentration printed on their products but did not specify what it accounted for. Table 6 
shows the calculated CBD amount detected by the GC-FID from the brand with the lowest 
quantity to the highest quantity of CBD as well as the quantity printed on the product label. 
Zatural had the highest amount of CBD at 13.83 mg, followed by Greenive at 4.39 mg, 
Hempio at 0.49 mg, O’Rmeas at 0.14 mg and Hemp Techniques had no detectable CBD. As 
shown, the actual CBD amount for every hemp oil sample were significantly lower than what 
was printed on the product label. This indicated the amount on the label was not intended to 
reflect the CBD amount. The number on the label is most likely indicative of the amount of 






















Table 6. Calculated CBD amount for each hemp oil sample and the amount printed on their 
product label. Amount advertised does not say specify what it alludes to. 
Brand Name Amount Advertised (mg) Calculated CBD Amount (mg) 
Hemp Techniques 30,000 0 
O’Rmeas 35,000 0.14 
Hempio 35,000 0.49 
Greenive 28,000 4.39 
Zatural 300 13.83 
 
3.8 GC-MSD of Hemp Oil 
Since Zatural was determined to have the highest concentration of CBD, it was ran 
through the GC-MSD for further chemical analysis. The GC chromatogram of Zatural 
showed one visible peak (Figure 39). which was suspected to be CBD. The mass spectra of 
the peak were analyzed and is shown in Figure 40. The parent peak was at m/z 231.2 and a 




Figure 39. GC-MSD chromatogram of Zatural hemp oil. 
 
Figure 40. Mass spectrum of the compound at retention time 10.6 min peak (Figure 39). The 

























IV.  Summary and Conclusions 
4.1 Challenges of GC Analysis  
The basic principle of gas chromatography is to separate organic compounds in a 
solution by injecting it into a sample port to be vaporized at noticeably high heat. CBD and 
THC have a relatively high boiling point of 180 °C and 157 °C respectively [20,21]. 
Subsequently, a high operating temperature is required to separate the cannabinoids from the 
sample matrix. Due to the harsh conditions and high temperatures of the GC, it could lead to 
a couple potential challenges researchers need to keep in mind when quantifying and 
examining CBD. First of all, at high temperatures, septum bleeding can produce ghost peaks 
in the chromatogram. Second, it is difficult to quantify CBD without taking into account the 
CBD produced through decarboxylation of its precursor, CBDA.  Lastly, CBD is susceptible 
to degradation and does not have an extensive shelf life. Hence, experiments involving CBD 
need to be conducted in a timely manner. 
4.2 Examination of CBD and Hemp Oils 
All things considered, the GC parameters optimized for this research were able to 
detect and identify CBD in commercial hemp oil products. There were no detectable traces of 
THC in any of the five hemp oils. This proves the products were in compliance with New 
York state and federal regulations. Additionally, hemp products are not legally required to 
explicitly state the concentration of CBD. This provides a loophole for companies to print 
product labels with a large concentration without specifying what it actually accounts for. 
The amount printed on the label most likely referred to the total amount of hemp oil extract in 
the bottle. However, to an uninformed consumer, the vagueness the vagueness of the product 
label could mislead them into thinking they are buying products containing a generous 
amount of CBD. This research supports the previous sentiment as four out of the five 
products tested had significantly lower CBD than what was printed on the label. One of them, 
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Hemp Techniques, did not even contain any detectable CBD despite the printed label reading 
30,000 mg.  
  Despite the numerous challenges faced in chemical analysis of CBD and THC, it is 
paramount to continue developing a reliable GC method to quantify cannabinoids, especially 
in the forensic field. Today, marijuana remains illegal on the federal level, however hemp has 
been removed from the Controlled Substance Act (CSA). However, law enforcement finds it 
difficult to differentiate between the two cannabis plants by sight alone since they are 
remarkably similar in appearance. As a result, forensic scientists rely on differentiating the 
two plants through chemical analysis. Not only is the GC useful in identifying various 
cannabinoids, but it can also accurately quantify how much is present in a sample. This is 
crucial since, legally, hemp and marijuana only differ by their THC concentration. Products 
containing CBD, such as hempseed oil, are becoming increasingly popular among consumers 
to help with anxiety, Post Traumatic Stress Disorder (PTSD), fatigue, muscle aches and many 
more. The result of the present study provides a scientific basis for low levels of CBD in 
hemp oil products that might suggest otherwise on their product label. By continuing to 
develop a dependable protocol for CBD analysis can companies be held accountable for 
product transparency, allowing consumers to truly make the most of the numerous health 
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